Literature DB >> 2302260

Arthritogenicity of minor cartilage collagens (types IX and XI) in mice.

M C Boissier1, G Chiocchia, M C Ronziere, D Herbage, C Fournier.   

Abstract

Native type II collagen, the major cartilage collagen, is immunogenic and arthritogenic in rodents. To investigate whether minor cartilage collagens are arthritogenic, we immunized DBA/1 mice with the pepsin-soluble fractions of type IX or type XI collagen emulsified in Freund's complete adjuvant. Both collagens were arthritogenic in DBA/1 mice after only 1 injection. However, the incidence of the polyarthritis was lower and the severity was lesser than with that induced by bovine type II collagen, even when a booster injection was administered. All mice developed a humoral response to the immunizing antigen, without any relationship to the arthritic status. Interestingly, competition experiments showed that antibodies raised against type XI collagen also bound with high avidity to type II collagen. In contrast, sera from type IX collagen-immunized mice did not react with either type II or type XI collagen. We conclude that types IX and XI minor cartilage collagens are both arthritogenic and immunogenic in DBA/1 mice. Whether the recognition of epitopes common to different collagens is relevant to the articular pathology remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302260     DOI: 10.1002/art.1780330101

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  25 in total

1.  Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis.

Authors:  Nathalie Saidenberg-Kermanac'h; Natacha Bessis; Delphine Lemeiter; Marie-Christine de Vernejoul; Marie-Christophe Boissier; Martine Cohen-Solal
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

2.  Stochastic pairing of heavy-chain and kappa light-chain variable gene families occurs in polyclonally activated B cells.

Authors:  A Kaushik; D H Schulze; F A Bonilla; C Bona; G Kelsoe
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

3.  Type II collagen serology: a guide to clinical responsiveness to oral tolerance?

Authors:  U Gimsa; J Sieper; J Braun; N A Mitchison
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

4.  Identification of rat susceptibility loci for adjuvant-oil-induced arthritis.

Authors:  J C Lorentzen; A Glaser; L Jacobsson; J Galli; H Fakhrai-rad; L Klareskog; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 5.  Experimental animal models resembling rheumatoid arthritis.

Authors:  P M Kaklamanis
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

6.  Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13.

Authors:  N Bessis; G Chiocchia; G Kollias; A Minty; C Fournier; D Fradelizi; M C Boissier
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

7.  Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease.

Authors:  R Fässler; P N Schnegelsberg; J Dausman; T Shinya; Y Muragaki; M T McCarthy; B R Olsen; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats.

Authors:  S Carlsén; A S Hansson; H Olsson; D Heinegård; R Holmdahl
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

9.  Auricular chondritis in NOD.DQ8.Abetao (Ag7-/-) transgenic mice resembles human relapsing polychondritis.

Authors:  Veena Taneja; Marie Griffiths; Marshall Behrens; Harvinder S Luthra; Chella S David
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

10.  Induction of arthritis in BALB/c mice by cartilage link protein: involvement of distinct regions recognized by T and B lymphocytes.

Authors:  Y Zhang; A Guerassimov; J Y Leroux; A Cartman; C Webber; R Lalic; E de Miguel; L C Rosenberg; A R Poole
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.